Hemodynamic changes and neurohumoral regulation during development of congestive heart failure in a model of epinephrine-induced cardiomyopathy in conscious rabbits

Journal of Cardiac Failure

Volumn 5, Issue 2, 1999, Pages 109-116

  Muders, Frank ^a,b   Friedrich, Erik ^a   Luchner, Andreas ^a   Pfeifer, Michael ^a   Ickenstein, Guntram ^a   Hamelbeck, Bernhard ^a   Riegger, Günter A J ^a   Elsner, Dietmar ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Catecholamine induced cardiomyopathy; Epinephrine; Heart failure; Neurohormones; Rabbit

Indexed keywords

ADRENALIN; NEUROHORMONE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CARDIOMYOPATHY; CATECHOLAMINE METABOLISM; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART DEVELOPMENT; HEART OUTPUT; HEMODYNAMICS; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0033061197     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(99)90033-7     Document Type: Article

References (39)

1. Pearce RM: Experimental myocarditis: a study of the histological changes following intravenous injections of adrenaline. J Exp Med 1906;8:400-9
2. Fleisher MS, Loeb L: Experimental myocarditis. Arch Intern Med 1909;3:78-91
3. Rona G, Chappel CI, Balazs T, Gaudry R: An infarct-like myocardial lesion and other toxic manifestations produced by isoproteronol in the rat. Arch Pathol 1959;67:443
4. Ferrans VJ, Hibbs RG, Walsh JJ: Histochemical and electron microscopical studies on the cardiac necrosis produced by sympathomimetic agents. Ann NY Acad Sci 1969;156:309-32
5. Szakacs JE, Cannon A: I-norepinephrine myocarditis. Am J Clin Pathol 1958;30:425
6. vanVliet PD, Burchell HB, Titus JL: Focal myocarditis associated with pheochromocytoma. N Engl J Med 1966;274:1102-8
7. Reichenbach DD, Benditt EP: Catecholamines and cardiomyopathy: the pathogenesis and potential importance of myofibrillar degeneration. Hum Pathol 1970;1:125-50
8. Cohen G, Heikkil RE: The generation of hydrogen peroxide, oxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 1974;204:317-22
9. Jiang JP, Chen V, Downing SE: Modulation of catecholamine cardiomyopathy by allopurinol. Am Heart J 1991; 122:115-21
10. Dhalla NS, Yates CJ, Lee SL, Singh A: Functional and subcellular changes in the isolated rat heart perfused with oxidized isoproterenol. J Mol Cell Cardiol 1978;10:31-41
11. Simons M, Downing SE: Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J 1985;9:297-304
12. Haft JI: Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis 1974;1:73-86
13. Fleckenstein AJ, Janke J, Döring HJ, Leder O: Myocardial fiber necrosis due to intracellular Ca overload - a new principle in cardiac pathophysiology. In Dhalla NS (ed): Recent advances in studies on cardiac structure and metabolism. Myocardial biology. University Park Press, Baltimore, 1974, pp. 563-80
14. Yates JC, Beamish RE, Dhalla NS: Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am Heart J 1981;102:210-21
15. Lee JC, Downing E: Ventricular function in norepinephrine-induced cardiomyopathic rabbits. Am J Physiol 1982;242:H191-6
16. Moss AJ, Vittands I, Schenk EA: Cardiovascular effects of sustained norepinephrine infusions. Circ Res 1966;18:596-603
17. Downing SE, Chen V: Myocardial injury following endogenous catecholamine release in rabbits. J Mol Cell Cardiol 1984;17:377-87
18. Teerlink JR, Pfeffer JM, Pfeffer MA: Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats. Circ Res 1994;75:105-13
19. Morton JJ, Riegger GAJ: A novel extraction method for plasma vasopressin and its application in a radioimmunoassay. J Endocrinol 1978;77:277-8
20. Shen YT, Cowley AW Jr, Vatner SF: Relative roles of cardiac and arterial baroreceptors in vasopressin regulation during hemorrhage in conscious dogs. Circ Res 1991;68: 1422-36
21. Hirsch AT, Dzau VJ, Creager MA: Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance. Circulation 1987; 75(suppl IV):36-48
22. Packer M: Neurohumoral interactions and adaptations in congestive heart failure. Circulation 1988;77:721-30
23. Hartley CJ, Cole JS: An ultrasonic pulsed Doppler system for measuring blood flow in small vessels. J Appl Physiol 1974;37:626-9
24. Haywood JR, Shaffer RA, Fastenow C, Fink GD, Brody MJ: Regional blood flow measurement with pulsed Doppler flowmeter in conscious rats. Am J Physiol 1981;24:H273-8
25. vanOrden DE, Farley DB, Fastenow C, Brody MJ: A technique for monitoring blood flow changes with miniaturized Doppler flow probes. Am J Physiol 1984;247: H1005-9
26. Riegger AJG, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K: Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects. Circulation 1988;77:398-406
27. Abassi Z, Haramati A, Hoffman A, Burnett JC Jr, Winaver J: Effect of converting enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol 1990;259:R84-9
28. Moe GW, Stopps TP, Angus C, Forster C, DeBold AJ, Armstrong PW: Alterations in serum sodium in relation to atrial natriuretic factor and other neuroendocrine variables in experimental pacing-induced heart failure. J Am Coll Cardiol 1989;13:173-9
29. Moe GW, Howard RJ, Angus C, DeBold AJ, Armstrong PW: Pathophysiologic role of changing atrial size and pressure in the modulation of atrial natriuretic factor during evolving experimental heart failure. Cardiovasc Res 1990; 24:570-7
30. Scriven TA, Burnett JC Jr: Effects of synthetic atrial natriuretic peptide on renal function and renin release in acute experimental heart failure. Circulation 1985;72:892-7
31. Holmer SR, Riegger AJ, Notheis WF, Kromer EP, Kochsiek K: Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin. Basic Res Cardiol 1987;82:101-8
32. Mancia G, Romero JC, Shepherd JT: Continuous inhibition of renin release in dogs by vagally innervated receptors in the cardiopulmonary region. Circ Res 1975;36: 529-35
33. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH: Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63:645-51
34. Curtiss C, Cohn JN, Vrobel T, Franciosa J: Role of the renin-angiotensin system in the systemic vasoconstriction of congestive heart failure. Circulation 1978;48:763-70
35. Schrier RW, Berl T, Anderson RJ: Osmotic and nonosmotic control of vasopressin release. Am J Physiol 1979; 236:F321-32
36. Bie P: Osmoreceptors, vasopressin, and control of renal water excretion. Physiol Rev 1980;60:961-1048
37. Arnolda L, McGrath BP, Cocks M, Johnston CI: Vasoconstrictor role for vasopressin in experimental heart failure in the rabbit. J Clin Invest 1986;78:674-9
38. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN: The neurohumoral axis in congestive heart failure. Ann Intern Med 1984;101:370-7
39. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E: Myocardial infarct size and ventricular function in rats. Cire Res 1979;44: 503-12